Telescope Implant for End-Stage Macular Degeneration is Already FDA Approved and Available to Patients 65 Years and Older Who Have Not Had Cataract Surgery viSionCAre grAnteD fDA APProvAL to initiAte CLiniCAL StUDy of the teLeSCoPe imPLAnt in PoSt-CAtArACt PAtientS Until now, CentraSight® , sponsored by VisionCare, Inc. was only available to patients 65 and over who have not had cataract surgery, a common procedure for seniors experiencing some vision loss. A new clinical trial launched in 2017 will evaluate the safety and effectiveness of the device for patients with End-Stage age- related macular degeneration, who have already had a cataract removed from the eye that will be implanted. In the study, the intraocular lens will be exchanged for the Implantable Miniature Telescope (by Dr. Isaac Lipshitz). If the trial is successful, it could potentially expand the eligibility for the procedure to many more with End-Stage AMD. Under current indications, the telescope implant is shown to improve vision and quality of life in appropriate patients who have End-Stage AMD, the most advanced form of AMD, in which individuals have lost central vision in both eyes. People living with End-Stage age-related macular degeneration find it difficult or impossible to recognize faces, read, watch TV or complete tasks requiring detailed vision. The condition is also associated with increased stress and depression as vision diminishes. It is the only FDA-approved medical device for End-Stage AMD and is Medicare eligible. The tiny telescope – about the size of a pea – works like a telephoto lens of a camera. Once implanted inside the eye, it magnifies images onto the healthy areas of the light- sensing retina to help improve central (straight-ahead) vision. The CentraSight treatment program has been developed to help patients see the things that are important to them, regain independence, and re-engage in everyday activities. The CentraSight team is made up of highly qualified professionals who have been specially trained in the CentraSight program to help patients follow the neces- sary steps for proper diagnosis, surgical 18 Macula Vision Research Foundation Spring/Summer 2017